Two-Drug Combination Approved for High Blood Pressure

MONDAY, Jan. 21 (HealthDay News) -- Tekturna HCT -- a combination of the drug Tekturna (aliskiren) and the diuretic hydrochlorothiazide -- has been approved by the U.S. Food and Drug Administration to treat high blood pressure, maker Novartis AG said Monday.

Clinical testing found the combination tablet "offers greater blood pressure reductions that either component alone," the drug maker said in a statement.

Approved last March, Tekturna inhibits rennin, an enzyme responsible for hypertension. The second drug, a diuretic, helps rid the body of excess water and salt.

Tektruna HCT will be available in early February, Novartis said. The most common adverse effects reported include dizziness, flu-like symptoms, diarrhea, cough and tiredness.

More information

The FDA has more about Tekturna.

Join the Discussion
blog comments powered by Disqus
 
You Might Also Like...
See It, Share It
PHOTO: Year In Pictures
Damien Meyer/AFP/Getty Images
PHOTO: James Franco and Seth Rogen in The Interview.
Ed Araquel/Sony/Columbia Pictures/AP Photo
PHOTO: Patrick Crawford is pictured in this photo from his Facebook page.
Meteorologist Patrick Crawford KCEN/Facebook
PHOTO: George Stinney Jr., the youngest person ever executed in South Carolina, in 1944, is seen in this undated file photo.
South Carolina Department of Archives and History/AP Photo